References
- Ahmad AK, Hui P, Litkouhi B, Azodi M, Rutherford T, McCarthy S, et al. 2014. Institutional review of primary Non-Hodgkin lymphoma of the female genital tract: a 33 year experience. International Journal of Gynecological Cancer 24:1250–1255.
- Brice P, Bastion Y, Lepage E, Brousse N, Haïoun C, Moreau P, et al. 1997. Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des lymphomes folliculaires. Groupe d'Etude des lymphomes de l'Adulte. Journal of Clinical Oncology 15:1110–1117.
- Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. 1971. Report of the committee on Hodgkin's disease staging classification. Disease classification. Cancer Research 31:1860–1861.
- Charlton I, Karnei RF, King FM, Norris J. 1974. Primary malignant reticuloendothelial disease involving the vagina, cervix, and corpus uteri. disease the, and uteri. Obstetrics and Gynecology 44:735–748.
- Harris NL, Scully RE. 1984. Malignant lymphoma and granulocytic sarcoma of the uterus and vagina. Cancer 53:2530–2545.
- Kahl B. 2012. Is there a role for “watch and wait” in follicular lymphoma in the rituximab era? Hematology Online 12:433–438.
- Korcum AF, Karadogan I, Aksu G, Aralasmak A, Erdogan G. 2007. Primary follicular lymphoma of the cervix uteri: a review. Annals of Haematology 86:623–630.
- Otter R, Gerrits WB. Sandt, Hermans J, Willemze R. 1989. Primary extranodal and nodal non-Hodgkin's lymphoma. A survey of a population-based registry. European Journal of Cancer and Clinical Oncology 25:1203–1210.
- Stroh EL, Besa PC, Cox JD, Fuller LM, Cabanillas FF. 1995. Treatment of patients with lymphomas of the uterus or cervix with combination chemotherapy and radiation therapy. Cancer 75:2392–2399.
- Vang R, Medeiros LJ, Ha CS, Deavers M. 2000. Non-Hodgkin's lymphomas involving the uterus: a clinicopathologic analysis of 26 cases. Modern Pathology 13:19–28.